Latest filing published 09 Sept 2026 for Tarsus Pharmaceuticals, Inc., €334k.
Filing timeline
BuySaleInsider track record
Seshadri Neervannan: trading record in brief
All filings by Seshadri Neervannan on record concern Tarsus Pharmaceuticals, Inc. We count 22 filings; the first trade dates from 15 March 2023 and the latest from 4 September 2026.
Sales make up the whole of the open-market record (16 sales, €2.2M). Outside the open market, there are 4 option exercises. So far in 2026, the count stands at no purchases and 6 sales.
The record was last updated on 9 September 2026 with an open-market sale (€334k) in Tarsus Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Seshadri Neervannan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,564 shares@ US$85.000.012% mcap19.6% of flowCommon StockSEC:0001827584-26-000013:0
- 2,989 shares@ US$66.7512.6% of flowCommon StockSEC:0001827584-26-000011:0
- 3,125 shares@ US$69.4213.8% of flowCommon StockSEC:0001827584-26-000009:0
- 26,287 sharesCommon StockSEC:0001827584-26-000007:0
- 8,366 shares@ US$76.6740.4% of flowCommon StockSEC:0001827584-26-000002:0
- 950 shares0Common StockSEC:0001827584-25-000003:0
- 2,605 shares@ US$46.298.1% of flowCommon StockSEC:0001819790-25-000058:0
- 21,264 sharesCommon StockSEC:0001819790-25-000043:0
- 13,245 sharesCommon StockSEC:0001819790-24-000043:0
- 372 shares@ US$12.890.3% of flowCommon StockSEC:0001827584-23-000004:0
- 360 shares@ US$13.280.3% of flowCommon StockSEC:0001827584-23-000002:0
- 5,097 sharesCommon StockSEC:0001209191-23-019876:0
12 of 12 declarations
